4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine

C143H205N43O2 — CID 158551791

IUPAC4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine
SMILESCC(C)(C)N1CCOCC1.CC(C)c1cnc(-n2cccc2)cn1.CC(C)c1cnc(-n2cccn2)cn1.CC(C)c1cnc(-n2ccnc2)cn1.CC(C)c1cnc(N2CCCC2)cn1.CC(C)c1cnc(N2CCCCC2)cn1.CC(C)c1cnc(N2CCCCC2C)cn1.CC(C)c1cnc(N2CCOCC2)cn1.CC1CCN(c2cnc(C(C)C)cn2)CC1.Cc1ccn(-c2cnc(C(C)C)cn2)n1.Cc1cn(-c2cnc(C(C)C)cn2)cn1.Cc1cnn(-c2cnc(C(C)C)cn2)c1.Cc1nccn1-c1cnc(C(C)C)cn1
InChIInChI=1S/2C13H21N3.C12H19N3.4C11H14N4.C11H17N3O.C11H17N3.C11H13N3.2C10H12N4.C8H17NO/c1-10(2)12-8-15-13(9-14-12)16-6-4-11(3)5-7-16;1-10(2)12-8-15-13(9-14-12)16-7-5-4-6-11(16)3;1-10(2)11-8-14-12(9-13-11)15-6-4-3-5-7-15;1-8(2)10-4-13-11(5-12-10)15-6-9(3)14-7-15;1-8(2)10-5-13-11(6-12-10)15-7-9(3)4-14-15;1-8(2)10-6-14-11(7-13-10)15-5-4-12-9(15)3;1-8(2)10-6-13-11(7-12-10)15-5-4-9(3)14-15;1-9(2)10-7-13-11(8-12-10)14-3-5-15-6-4-14;2*1-9(2)10-7-13-11(8-12-10)14-5-3-4-6-14;1-8(2)9-5-13-10(6-12-9)14-4-3-11-7-14;1-8(2)9-6-12-10(7-11-9)14-5-3-4-13-14;1-8(2,3)9-4-6-10-7-5-9/h2*8-11H,4-7H2,1-3H3;8-10H,3-7H2,1-2H3;4*4-8H,1-3H3;7-9H,3-6H2,1-2H3;7-9H,3-6H2,1-2H3;3-9H,1-2H3;2*3-8H,1-2H3;4-7H2,1-3H3
InChIKeyHPUQOKYGUVYQPT-UHFFFAOYSA-N
MW2558.51 g/mol
LogP27.50
Rot. Bonds24

About 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine

4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine (PubChem CID 158551791) has the molecular formula C143H205N43O2 and a molecular weight of 2558.51 g/mol. Its IUPAC name is 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine.

Molecular Properties

Compound Name4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine
PubChem CID158551791
Molecular FormulaC143H205N43O2
Molecular Weight2558.51 g/mol
Exact Mass2556.73
IUPAC Name4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine
SMILESCC(C)(C)N1CCOCC1.CC(C)c1cnc(-n2cccc2)cn1.CC(C)c1cnc(-n2cccn2)cn1.CC(C)c1cnc(-n2ccnc2)cn1.CC(C)c1cnc(N2CCCC2)cn1.CC(C)c1cnc(N2CCCCC2)cn1.CC(C)c1cnc(N2CCCCC2C)cn1.CC(C)c1cnc(N2CCOCC2)cn1.CC1CCN(c2cnc(C(C)C)cn2)CC1.Cc1ccn(-c2cnc(C(C)C)cn2)n1.Cc1cn(-c2cnc(C(C)C)cn2)cn1.Cc1cnn(-c2cnc(C(C)C)cn2)c1.Cc1nccn1-c1cnc(C(C)C)cn1
InChIInChI=1S/2C13H21N3.C12H19N3.4C11H14N4.C11H17N3O.C11H17N3.C11H13N3.2C10H12N4.C8H17NO/c1-10(2)12-8-15-13(9-14-12)16-6-4-11(3)5-7-16;1-10(2)12-8-15-13(9-14-12)16-7-5-4-6-11(16)3;1-10(2)11-8-14-12(9-13-11)15-6-4-3-5-7-15;1-8(2)10-4-13-11(5-12-10)15-6-9(3)14-7-15;1-8(2)10-5-13-11(6-12-10)15-7-9(3)4-14-15;1-8(2)10-6-14-11(7-13-10)15-5-4-12-9(15)3;1-8(2)10-6-13-11(7-12-10)15-5-4-9(3)14-15;1-9(2)10-7-13-11(8-12-10)14-3-5-15-6-4-14;2*1-9(2)10-7-13-11(8-12-10)14-5-3-4-6-14;1-8(2)9-5-13-10(6-12-9)14-4-3-11-7-14;1-8(2)9-6-12-10(7-11-9)14-5-3-4-13-14;1-8(2,3)9-4-6-10-7-5-9/h2*8-11H,4-7H2,1-3H3;8-10H,3-7H2,1-2H3;4*4-8H,1-3H3;7-9H,3-6H2,1-2H3;7-9H,3-6H2,1-2H3;3-9H,1-2H3;2*3-8H,1-2H3;4-7H2,1-3H3
InChIKeyHPUQOKYGUVYQPT-UHFFFAOYSA-N
XLogP27.50
TPSA459.11 Ų
H-Bond Donors
H-Bond Acceptors45
Rotatable Bonds24
Heavy Atoms188
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002558.51
LogP ≤ 527.50
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1045

Analyze 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
The IUPAC name of 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine (CID 158551791) is 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine.
What is the SMILES notation for 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
The canonical SMILES for 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine is CC(C)(C)N1CCOCC1.CC(C)c1cnc(-n2cccc2)cn1.CC(C)c1cnc(-n2cccn2)cn1.CC(C)c1cnc(-n2ccnc2)cn1.CC(C)c1cnc(N2CCCC2)cn1.CC(C)c1cnc(N2CCCCC2)cn1.CC(C)c1cnc(N2CCCCC2C)cn1.CC(C)c1cnc(N2CCOCC2)cn1.CC1CCN(c2cnc(C(C)C)cn2)CC1.Cc1ccn(-c2cnc(C(C)C)cn2)n1.Cc1cn(-c2cnc(C(C)C)cn2)cn1.Cc1cnn(-c2cnc(C(C)C)cn2)c1.Cc1nccn1-c1cnc(C(C)C)cn1.
What is the InChIKey of 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
The InChIKey is HPUQOKYGUVYQPT-UHFFFAOYSA-N. The full InChI is InChI=1S/2C13H21N3.C12H19N3.4C11H14N4.C11H17N3O.C11H17N3.C11H13N3.2C10H12N4.C8H17NO/c1-10(2)12-8-15-13(9-14-12)16-6-4-11(3)5-7-16;1-10(2)12-8-15-13(9-14-12)16-7-5-4-6-11(16)3;1-10(2)11-8-14-12(9-13-11)15-6-4-3-5-7-15;1-8(2)10-4-13-11(5-12-10)15-6-9(3)14-7-15;1-8(2)10-5-13-11(6-12-10)15-7-9(3)4-14-15;1-8(2)10-6-14-11(7-13-10)15-5-4-12-9(15)3;1-8(2)10-6-13-11(7-12-10)15-5-4-9(3)14-15;1-9(2)10-7-13-11(8-12-10)14-3-5-15-6-4-14;2*1-9(2)10-7-13-11(8-12-10)14-5-3-4-6-14;1-8(2)9-5-13-10(6-12-9)14-4-3-11-7-14;1-8(2)9-6-12-10(7-11-9)14-5-3-4-13-14;1-8(2,3)9-4-6-10-7-5-9/h2*8-11H,4-7H2,1-3H3;8-10H,3-7H2,1-2H3;4*4-8H,1-3H3;7-9H,3-6H2,1-2H3;7-9H,3-6H2,1-2H3;3-9H,1-2H3;2*3-8H,1-2H3;4-7H2,1-3H3.
What are the key properties of 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine has a molecular weight of 2558.51 g/mol, XLogP of 27.50, 24 rotatable bonds, 0 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 4-tert-butylmorpholine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(3-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpyrazol-1-yl)-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrazol-1-ylpyrazine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine is sourced from PubChem (CID 158551791), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).